Recent insights into pre- and postnatal pyridoxal phosphate deficiency, a treatable metabolic encephalopathy.
Baxter
Peter
P
D017668:Age of Onset; D000927:Anticonvulsants / Q000627:therapeutic use; D001921:Brain / Q000503:physiopathology; D001928:Brain Diseases, Metabolic / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D003937:Diagnosis, Differential; D004569:Electroencephalography; D004827:Epilepsy / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D007223:Infant; D002955:Leucovorin / Q000378:metabolism / Q000627:therapeutic use; D010641:Phenotype; D011734:Pyridoxaminephosphate Oxidase / Q000172:deficiency* / Q000378:metabolism; D011736:Pyridoxine / Q000378:metabolism / Q000627:therapeutic use
D000927:Anticonvulsants; D011734:Pyridoxaminephosphate Oxidase; D011736:Pyridoxine; D002955:Leucovorin